| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
294.81(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
| Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
| Total People Sold |
2 |
9 |
9 |
12 |
| Total Sell Transactions |
2 |
11 |
13 |
29 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Severino Michael |
EVP, R&D and CSO |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$3,273,792 |
D/D |
(27,683) |
134,924 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2018-02-28 |
4 |
S |
$117.85 |
$303,928 |
D/D |
(2,579) |
130,447 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$3,071,922 |
D/D |
(25,976) |
133,026 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2018-02-28 |
4 |
S |
$117.77 |
$157,458 |
D/D |
(1,337) |
93,312 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$1,499,892 |
D/D |
(12,683) |
94,649 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2018-02-28 |
4 |
S |
$119.44 |
$4,601,954 |
D/D |
(38,528) |
164,863 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$3,359,412 |
D/D |
(28,407) |
203,391 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$2,059,853 |
D/D |
(17,418) |
72,800 |
|
- |
|
| Michael Robert A. |
VP, Controller |
• – – |
2018-02-28 |
4 |
S |
$119.43 |
$512,853 |
D/D |
(4,294) |
6,876 |
|
- |
|
| Michael Robert A. |
VP, Controller |
• – – |
2018-02-28 |
4 |
D |
$118.26 |
$282,287 |
D/D |
(2,387) |
11,170 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2018-02-28 |
4 |
S |
$117.88 |
$976,084 |
D/D |
(8,280) |
313,012 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2018-02-28 |
4 |
D |
$118.26 |
$9,400,606 |
D/D |
(79,491) |
321,292 |
|
- |
|
| Michael Robert A. |
VP, Controller |
• – – |
2018-02-20 |
4 |
S |
$120.29 |
$119,351 |
D/D |
(992) |
13,557 |
|
- |
|
| Michael Robert A. |
VP, Controller |
• – – |
2018-02-19 |
4 |
D |
$118.60 |
$99,387 |
D/D |
(838) |
14,549 |
|
- |
|
| Michael Robert A. |
VP, Controller |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,380 |
15,387 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,533 |
107,332 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
126,946 |
400,783 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,316 |
90,218 |
|
- |
|
| Richmond Timothy J. |
SVP, Human Resources |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
21,822 |
47,900 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
45,420 |
151,152 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
44,257 |
159,002 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
48,255 |
231,798 |
|
- |
|
| Severino Michael |
EVP, R&D and CSO |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
47,685 |
162,607 |
|
- |
|
| Richmond Timothy J. |
SVP, Human Resources |
• – – |
2017-12-18 |
4 |
S |
$98.45 |
$8,569,053 |
D/D |
(87,040) |
26,078 |
|
- |
|
| Richmond Timothy J. |
SVP, Human Resources |
• – – |
2017-12-18 |
4 |
OE |
$35.88 |
$3,122,995 |
D/D |
87,040 |
113,118 |
|
- |
|
765 Records found
|
|
Page 19 of 31 |
|
|
0.47 (0.28%) 
